Patent · US Expired

Method and compositions for controlling oral and pharyngeal pain using capsaicinoids

US5762963A · kind A · utility

136Cited by
16References
45Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 7, 1995
Grant dateJun 9, 1998
Priority date
Expiry dateJun 7, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/165
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions are provided for the oral delivery of temporally increasing concentrations of capsaicin, its derivatives, and analogs (collectively, "capsaicinoids"), to provide oral or pharyngeal analgesia while minimizing sensations of nausea and burning associated with the oral administration of capsaicinoids. The methods and compositions described herein soothe and relieve oral or pharynx pain. In one embodiment, one or more capsaicinoids are dispersed within a lollipop, with successively decreasing concentrations of capsaicin from the center out to the periphery, and administered to a patient in need of amelioration of oral pain. Alternatively, the capsaicinoid can be dispersed, with decreasing concentrations from the center to the periphery, in a tablet, caplet, lozenge, troche, pill, candy, or similar formulation. Capsaicinoids include dihydrocapsaicin, norhydrocapsaicin, homocapsaicin, homodihydrocapsaicin I, norhydrocapsaicin, homodihydrocapsaicin, nordihydrocapsaicin, civamide, nonivamide, NE-19550 (also called olvanil), NE-21610, NE-28345 (also called N-oleyl-homovanillamide), their analogs, and derivatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.